the completed trial (results due shortly) is specifically for their TGA and FDA submission. So unless the regulator specifically requests further trials then they wont do another trial is my understanding. Page 41 of the prospectus has the detail. This trial is very similar to the study they did in the Californian university approx 3 years ago. So the chances of it being a dud is low in my opinion
LTP Price at posting:
34.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)